Vivos Therapeutics Inc (NAS:VVOS)
$ 2.1 -0.07 (-3.23%) Market Cap: 6.78 Mil Enterprise Value: 6.27 Mil PE Ratio: 0 PB Ratio: 10.00 GF Score: 59/100

Vivos Therapeutics Inc at Benzinga Global Small Cap Investor Conference (Virtual) Transcript

Dec 09, 2021 / 06:55PM GMT
Release Date Price: $71.5 (+2.14%)
Brent Slava
Benzinga - Moderator

And I want to bring on Vivos Therapeutics' Co-Founder and CEO, Kirk Huntsman. Kirk, nice to see you here.

Kirk Huntsman
Vivos Therapeutics, Inc. - Chairman & CEO

Hi, Brent. Nice to be here. Thanks for having us.

Brent Slava
Benzinga - Moderator

Yeah. And it looks like your CFO, Brad, is also here. Nice to meet you, Brad. Nice to see you.

Brad Amman
Vivos Therapeutics, Inc. - CFO

Yeah, good to see you, Brent.

Brent Slava
Benzinga - Moderator

Cool. Well, I will let you guys have at it. I see some slides backstage and who -- whichever one of you guys is controlling that just make it full screen if you can, and we should be good to go.

Kirk Huntsman;Brent Slava
Vivos Therapeutics, Inc. - Chairman & CEO;Benzinga - Moderator

So I thought I did. Let me make sure. How's that? Does that look full screen now?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot